Warberg Asset Management LLC Kiromic Biopharma, Inc. Transaction History

Warberg Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.26 - $0.87 $19,200 - $64,246	-73,847 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.6 - $1.82 $24,019 - $72,858	40,032 Added 118.39%	73,847 $63,000
Q4 2021 Feb 14, 2022	BUY	$1.53 - $3.12 $33,376 - $68,062	21,815 Added 181.79%	33,815 $52,000
Q3 2021 Nov 15, 2021	SELL	$2.69 - $4.94 $137,190 - $251,940	-51,000 Reduced 80.95%	12,000 $37,000
Q2 2021 Aug 16, 2021	BUY	$4.81 - $10.34 $303,030 - $651,420	63,000 New	63,000 $303,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $22.2M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Warberg Asset Management LLC with notifications on news.